The combined DEA and correlative analysis of MHC-I–related transcripts is presented in Figure 6A. NF-κB drives MHC-I presentation (62), and its inhibitor NFKBIA is downregulated in T1D, yet positively associates with α score. Here, NFKBIA is linked to type 1 diabetes mellitus.